Literature DB >> 32584531

Long-acting injectable antipsychotics: choosing the right dose.

David Carlone1, Nicholas Delva1.   

Abstract

Year:  2020        PMID： 32584531      PMCID： PMC7828926          DOI： 10.1503/jpn.200015

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

Review 1.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

Review 2.  Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics.

Authors:  Jose de Leon
Journal:  Neuropharmacology       Date:  2019-05-28       Impact factor: 5.250

Review 3.  Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Authors:  C Hiemke; N Bergemann; H W Clement; A Conca; J Deckert; K Domschke; G Eckermann; K Egberts; M Gerlach; C Greiner; G Gründer; E Haen; U Havemann-Reinecke; G Hefner; R Helmer; G Janssen; E Jaquenoud; G Laux; T Messer; R Mössner; M J Müller; M Paulzen; B Pfuhlmann; P Riederer; A Saria; B Schoppek; G Schoretsanitis; M Schwarz; M Silva Gracia; B Stegmann; W Steimer; J C Stingl; M Uhr; S Ulrich; S Unterecker; R Waschgler; G Zernig; G Zurek; P Baumann
Journal:  Pharmacopsychiatry       Date:  2017-09-14       Impact factor: 5.788

4.  Need for Bioequivalence Standards that Reflect the Clinical Importance of the Complex Pharmacokinetics of Paliperidone Palmitate Long-Acting Injectable Suspension.

Authors:  Ric M Procyshyn; Joel W Lamoure; Martin A Katzman; Pamela L Skinner; Stephen E Sherman
Journal:  J Pharm Pharm Sci       Date:  2019       Impact factor: 2.327

5.  Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia.

Authors:  Brianne Brown; Ibrahim Turkoz; Branislav Mancevski; Maju Mathews
Journal:  Early Interv Psychiatry       Date:  2019-09-13       Impact factor: 2.732

6.  Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate.

Authors:  Charmi Patel; Bruno Emond; Marie-Hélène Lafeuille; Aurélie Côté-Sergent; Patrick Lefebvre; Neeta Tandon; Antoine C El Khoury
Journal:  Drugs Real World Outcomes       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.